Regeneron Pharmaceuticals 2024 JPMorgan Healthcare Conference

Regeneron presented its strategy and business update at the J.P. Morgan Healthcare Conference in January 2024, showcasing its portfolio of marketed products including EYLEA, Dupixent, and Libtayo, alongside late-stage and investigational candidates. The presentation covered pipeline programs, clinical milestones, manufacturing initiatives, and commercial progress across oncology, immunology, and other therapeutic areas.